Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.011 USD | -15.69% | +19.57% | +13.40% |
Valuation
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Capitalization 1 | 60.69 | 15.45 | 5.136 | 5.014 | 5.815 | 2.519 |
Enterprise Value (EV) 1 | 59.04 | 14.37 | 4.226 | 3.401 | 6.34 | 3.706 |
P/E ratio | -40.7 x | -16.2 x | -16.9 x | -7.71 x | -3.87 x | -3.79 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 24.8 x | 15.7 x | 2.41 x | 3.19 x | 2.4 x | 0.13 x |
EV / Revenue | 24.2 x | 14.6 x | 1.98 x | 2.17 x | 2.61 x | 0.2 x |
EV / EBITDA | -121 x | -14.6 x | -16.3 x | -5.57 x | -5.31 x | -9.8 x |
EV / FCF | 43.5 x | -12.8 x | 501 x | -8.45 x | -9.01 x | 55 x |
FCF Yield | 2.3% | -7.81% | 0.2% | -11.8% | -11.1% | 1.82% |
Price to Book | 77.7 x | 15.4 x | 5.84 x | 3.1 x | 2.74 x | 1.38 x |
Nbr of stocks (in thousands) | 51,434 | 51,513 | 52,978 | 70,323 | 81,903 | 89,978 |
Reference price 2 | 1.180 | 0.3000 | 0.0970 | 0.0713 | 0.0710 | 0.0280 |
Announcement Date | 12/26/18 | 4/15/19 | 3/31/20 | 3/2/21 | 4/25/22 | 4/17/23 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Net sales 1 | 2.443 | 0.9823 | 2.131 | 1.57 | 2.425 | 18.81 |
EBITDA 1 | -0.4863 | -0.9814 | -0.2597 | -0.6101 | -1.195 | -0.3781 |
EBIT 1 | -0.4907 | -0.9851 | -0.2662 | -0.624 | -1.291 | -0.6057 |
Operating Margin | -20.09% | -100.28% | -12.49% | -39.75% | -53.22% | -3.22% |
Earnings before Tax (EBT) 1 | -1.488 | -0.9507 | -0.3017 | -0.5324 | -1.439 | -0.6332 |
Net income 1 | -1.488 | -0.9507 | -0.3017 | -0.5324 | -1.439 | -0.6332 |
Net margin | -60.93% | -96.78% | -14.16% | -33.92% | -59.35% | -3.37% |
EPS 2 | -0.0290 | -0.0185 | -0.005750 | -0.009251 | -0.0184 | -0.007386 |
Free Cash Flow 1 | 1.358 | -1.122 | 0.008433 | -0.4024 | -0.7034 | 0.0674 |
FCF margin | 55.57% | -114.26% | 0.4% | -25.63% | -29% | 0.36% |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 12/26/18 | 4/15/19 | 3/31/20 | 3/2/21 | 4/25/22 | 4/17/23 |
Balance Sheet Analysis
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | 0.53 | 1.19 |
Net Cash position 1 | 1.65 | 1.09 | 0.91 | 1.61 | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | -0.4395 x | -3.138 x |
Free Cash Flow 1 | 1.36 | -1.12 | 0.01 | -0.4 | -0.7 | 0.07 |
ROE (net income / shareholders' equity) | -207% | -106% | -32% | -42.5% | -76.8% | -31.8% |
ROA (Net income/ Total Assets) | -21.6% | -39.3% | -13.4% | -25.2% | -26.4% | -8.56% |
Assets 1 | 6.897 | 2.419 | 2.248 | 2.111 | 5.452 | 7.393 |
Book Value Per Share 2 | 0.0200 | 0.0200 | 0.0200 | 0.0200 | 0.0300 | 0.0200 |
Cash Flow per Share 2 | 0.0300 | 0.0200 | 0.0200 | 0.0200 | 0.0100 | 0 |
Capex 1 | 0 | - | 0.04 | 0 | 0.36 | 0.1 |
Capex / Sales | 0.19% | - | 1.81% | 0.14% | 14.75% | 0.55% |
Announcement Date | 12/26/18 | 4/15/19 | 3/31/20 | 3/2/21 | 4/25/22 | 4/17/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+13.40% | 2.43M | |
+10.48% | 67.6B | |
+12.37% | 18.21B | |
+20.16% | 13.41B | |
+10.20% | 13.37B | |
+16.25% | 9.94B | |
-32.22% | 5.74B | |
-10.49% | 5.57B | |
-3.43% | 4.91B | |
-4.44% | 4.87B |
- Stock Market
- Equities
- AMMJ Stock
- Financials American Cannabis Company, Inc.